Oct 24, 2016, 09:28 AM by Michael Croft

The Economist | Juno Therapeutics, a young biotech firm focused on cancer, promises both risk and reward with its attempt to master the T-cell. The firm is on the forefront of the most promising area of cancer treatments in decades.

Oct 24, 2016, 09:07 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC, UNITED STATES - Oct 24, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is participating in a free webinar hosted by QuintilesIMS, where expert guest speakers will highlight regulatory trends, technology innovation and industry perspectives surrounding Continuous Glucose Monitoring (CGM) to help sponsors develop smarter diabetes clinical trials

Oct 24, 2016, 02:46 AM by Michael Croft

SHIRLEY, NY - Oct 24, 2016 - As is known, it has long been a dream in medicine and pharmacy to use peptides as drugs. The driving force for such application is based on the ability of these compounds to improve the antibodies in the body

Oct 21, 2016, 09:50 AM by Michael Croft

Oct 20, 2016, 23:44 PM by Michael Croft

SHIRLEY, NY - Oct 21, 2016 - October 20, 2016, experienced scientists in Creative Enzymes introduced a part of newly-updated products belonging to hydrolases products, which symbolized the beginning of developing hydrolases products in Creative Enzymes

Oct 20, 2016, 13:45 PM by Michael Croft

Bio-IT World | Last week, Illumina announced that it is creating an array for genome-wide association studies (GWAS) by the Human Heredity and Health in Africa (H3Africa) Initiative. The array—which isn’t available yet—will be include 2.5 million variations of specific interest to African populations.

Oct 20, 2016, 13:38 PM by Michael Croft

WILMINGTON, NC, UNITED STATES - Oct 20, 2016 - As mentioned earlier in this report, the procedure provides relief of pain and symptoms associated with herniated discs, bulging or protruding intervertebral discs, degenerative disc disease, sciatica and chronic pain

Oct 20, 2016, 10:48 AM by Michael Croft

Chemical & Engineering News | In a critical validation for a biotech firm espousing an unusual business model, Perlara has struck a deal to develop lysosomal storage disorder treatments with Novartis. The big pharma company will also make an undisclosed investment in the rare-disease-focused firm.

Oct 20, 2016, 10:30 AM by Michael Croft

Bio-IT World News Brief | The American Society of Human Genetics annual meeting is currently underway in Vancouver, Canada. Here are some of the product news and company announcements released so far this week. Highlights include the Genome Aggregation Database, Illumina’s contribution to ClinVar, BabySeq news, and more.

Oct 20, 2016, 10:09 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Oct 20, 2016 - Congenica, a clinical interpretation partner for the UK 100,000 Genomes Project, has announced that its whole genome analysis platform Sapientia™ is detecting clinically relevant variants in over 35% of diagnostics reports returned to the NHS Genomic Medicine Centres (GMCs) for the Pilot and Main Phase studies

Oct 20, 2016, 09:32 AM by Michael Croft

BOSTON, MA, USA - Oct 19, 2016 -  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced that Pine Biotech and Medexprim have been selected as the grand prize winners of its 2016 President’s Startup Challenge

Oct 20, 2016, 09:29 AM by Michael Croft

NEW YORK, NY, UNITED KINGDOM - Oct 20, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that four start-up companies have been selected for The Hive, Elsevier's new incubator project for biotech and pharmaceutical start-up firms

Oct 19, 2016, 16:38 PM by Michael Croft

WILMINGTON, NC, UNITED STATES - Oct 20, 2016 - Decompression relieves pressure that builds up on the discs and nerves. The task of relieving pain comes about as a result of drawing areas of herniated disc back into place

Oct 19, 2016, 12:54 PM by Michael Croft

NEW YORK, NY - Oct 19, 2016 - - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the new release of Reaxys, a chemistry research experience that delivers relevant literature and data more than twice as fast as any other solution

Oct 19, 2016, 12:49 PM by Michael Croft

NEW YORK, NY - Oct 19, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, has today announced that the 2016 Reaxys ChemSearch Challenge is now live, following its successful debut last year

Oct 19, 2016, 09:52 AM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Oct 19, 2016 - James Umen, Ph.D., associate member at Donald Danforth Plant Science Center, and colleagues have discovered a way to make algae better oil producers without sacrificing growth

Oct 19, 2016, 09:38 AM by Michael Croft

WIRED | We must access genetic info from millions of cancer patients to make the connections necessary to battle the disease. It won't be easy, but Eric Schadt believes we can do it.

Oct 19, 2016, 09:18 AM by Michael Croft

The Boston Globe | The gene-editing technology company with Cambridge operations sold 4 million share at $14 each. It had planned to sell 4.7 million shares at $15 to $17 apiece.

Oct 19, 2016, 08:24 AM by Michael Croft

PRINCETON, NJ - Oct 19, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that the Office of Generic Drugs (OGD), US Food and Drug Administration (FDA) has awarded it a multi-year research grant to create and validate a physiologically-based pharmacokinetic (PBPK) modeling and simulation framework that complements existing models within the Simcyp® Population-based Simulator

Oct 19, 2016, 06:59 AM by Michael Croft

OXFORDSHIRE, UK - Oct 19, 2016 - Oxford Genetics Ltd, a leading biotech which specialises in DNA design, protein expression optimization and cell line development technologies and services, has moved its operations to new state-of-the-art laboratories at The Oxford Science Park